Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Hackeng

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Journal of Thrombosis and Haemostasis : JTH|March 9, 2011
A case-control study on platelet reactivity in patients with coronary stent thrombosisH J Bouman, J W van Werkum, N J Breet, et al.
European Journal of Clinical Pharmacology|September 14, 2023
The effect of renal impairment and obesity on anti-Xa peak and trough levels in patients receiving therapeutic doses of nadroparin: a comparison with control patientsL Mast, M Y M Peeters, M Söhne, et al.
Thrombosis Research|August 18, 2020
Anti Xa activity after high dose LMWH thrombosis prophylaxis in covid 19 patients at the intensive care unitE A Vlot, E J Van den Dool, C M Hackeng, et al.
Heart (British Cardiac Society)|May 23, 2015
The hypercoagulable profile of patients with stent thrombosisR Loeffen, T C Godschalk, R van Oerle, et al.
Platelets|November 4, 2008
The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidenceJ W van Werkum, A M Harmsze, E H A M Elsenberg, et al.
Journal of Thrombosis and Haemostasis : JTH|December 31, 2009
Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrelH J Bouman, E Parlak, J W van Werkum, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 16, 2011
Is platelet inhibition due to thienopyridines increased in elderly patients, in patients with previous stroke and patients with low body weight as a possible explanation of an increased bleeding risk?N J Breet, H E van Donkersgoed, J W van Werkum, et al.
Journal of Thrombosis and Haemostasis : JTH|January 31, 2017
The effect of correcting VerifyNow P2Y12 assay results for hematocrit in patients undergoing percutaneous coronary interventionsP W A Janssen, T O Bergmeijer, T C Godschalk, et al.
Thrombosis Research|September 3, 2022
Postoperative myocardial injury and platelet reactivity in patients undergoing vascular surgery: The platelet reactivity and postoperative myocardial injury after major vascular surgery (PROMISE) studyK L Zheng, W L Bor, L M Vernooij, et al.
Thrombosis and Haemostasis|February 4, 2010
The influence of variation in the P2Y12 receptor gene on in vitro platelet inhibition with the direct P2Y12 antagonist cangrelorH J Bouman, J W van Werkum, G Rudez, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Thrombosis and Haemostasis : JTH|March 9, 2011
A case-control study on platelet reactivity in patients with coronary stent thrombosisH J Bouman, J W van Werkum, N J Breet, et al.
European Journal of Clinical Pharmacology|September 14, 2023
The effect of renal impairment and obesity on anti-Xa peak and trough levels in patients receiving therapeutic doses of nadroparin: a comparison with control patientsL Mast, M Y M Peeters, M Söhne, et al.
Thrombosis Research|August 18, 2020
Anti Xa activity after high dose LMWH thrombosis prophylaxis in covid 19 patients at the intensive care unitE A Vlot, E J Van den Dool, C M Hackeng, et al.
Heart (British Cardiac Society)|May 23, 2015
The hypercoagulable profile of patients with stent thrombosisR Loeffen, T C Godschalk, R van Oerle, et al.
Platelets|November 4, 2008
The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidenceJ W van Werkum, A M Harmsze, E H A M Elsenberg, et al.
Journal of Thrombosis and Haemostasis : JTH|December 31, 2009
Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrelH J Bouman, E Parlak, J W van Werkum, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 16, 2011
Is platelet inhibition due to thienopyridines increased in elderly patients, in patients with previous stroke and patients with low body weight as a possible explanation of an increased bleeding risk?N J Breet, H E van Donkersgoed, J W van Werkum, et al.
Journal of Thrombosis and Haemostasis : JTH|January 31, 2017
The effect of correcting VerifyNow P2Y12 assay results for hematocrit in patients undergoing percutaneous coronary interventionsP W A Janssen, T O Bergmeijer, T C Godschalk, et al.
Thrombosis Research|September 3, 2022
Postoperative myocardial injury and platelet reactivity in patients undergoing vascular surgery: The platelet reactivity and postoperative myocardial injury after major vascular surgery (PROMISE) studyK L Zheng, W L Bor, L M Vernooij, et al.
Thrombosis and Haemostasis|February 4, 2010
The influence of variation in the P2Y12 receptor gene on in vitro platelet inhibition with the direct P2Y12 antagonist cangrelorH J Bouman, J W van Werkum, G Rudez, et al.
Pageof 3